Israel Real Economy · 27 stories · Updated Aug 14, 2026
Lead storyLeon Koffler controls Super-Pharm, Union Group's Horesh holds about a third, and Shufersal owns Be. Who owns Israel's pharmacy chains and why it matters.
Read →Deeper coverage tracks inside Health & Biotech
Teva, Taro, Dexcel, Perrigo
Israeli device makers develop tools for surgery, imaging and treatment, while acquisitions connect local businesses with…
Israeli digital health companies: software for remote consultations, triage and medical imaging, and the health systems…
Sciences Venture Capital: aMoon, Pontifax, Israel Biotech Fund, OrbiMed
Long-form reference entries in Health & Biotech
The Weizmann Institute's tech transfer arm earned more than $1.5bn in royalties on a single multiple sclerosis drug. The…
Yeda — the Weizmann Institute's tech-transfer arm — is the prototype Israeli university commercialisation vehicle. Its l…
Page 1 of 3
Leon Koffler controls Super-Pharm, Union Group's Horesh holds about a third, and Shufersal owns Be. Who owns Israel's pharmacy chains and why it matte…
BOL Pharma sought a court trustee, Panaxia negotiated a distressed sale, and Tikun Olam closed its farms, while InterCure's Canndoc reported NIS 270.2…
Israel has 1,800 life-sciences companies but almost no blockbuster drugs. This ecosystem includes Teva, InMode, AI health, Weizmann IP, and aMoon capi…
Tofes 17 is the authorization form Israel's four health funds issue for external medical services. It is the commercial gate that decides which foreig…
Friends of Tel Aviv Sourasky Medical Center (Ichilov), EIN 13-3310053, reported $16.96 million in revenue for FY2024, more than double its FY2022 tota…
InMode, founded by Moshe Mizrahy and Dr. Michael Kreindel, is an Israeli medical-aesthetic device maker. It uses proprietary radiofrequency technology…
Teva paid $40.5 billion for Allergan's generics business in 2016. By mid-2026 its net debt had fallen to $12.9 billion, and its 2027 target is leverag…
Clalit's Petah Tikva tertiary flagship (Rabin Medical Center) and Israel's #1 transplant center. Top-tier in the hospitals Answer Index — everywhere,…
Israel moved most cannabis prescribing into its HMOs on April 1, 2024. Separately, a 165% tariff on Canadian imports was vetoed, upheld by courts, and…
